Leerink Partners

Following the June 2025 opening of its London office, the program runs in both New York and London. There is no separate spring week, insight program, or off-cycle scheme: the summer analyst class is the firm's one structured student entry point. For a healthcare-focused candidate that single program is effectively the only campus door into the bank, so it competes for an application slot against broad bulge-bracket programs recruiting across every sector.

Independent reporting found that in 2025 it held the largest market share of any bank in biopharma and broader healthcare equity offerings per Dealogic, overtaking Jefferies and finishing ahead of JPMorgan and Goldman Sachs. It also runs MEDACorp, an in-house network of physicians and specialists that supplies primary medical insight to its deal and research teams. For an applicant this concentrates early experience in healthcare deal flow rather than spreading it across sectors – deep but narrow – which makes the firm a strong first choice for someone set on healthcare and a weaker fit for someone wanting to keep sectors open.